chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Atrial fibrillation, Blood potassium normal, COVID-19, Chest X-ray normal
Clinical narrative: 71 y.o. male patient with history of A-fib, COPD, CAD, alcohol use disorder presented to Hospital following a fall at home. Covid positive with hypoxia.   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms:4/4/23 Symptoms present on admission: Chest congestion, diarrhea Date of covid positive test: 4/5/2023 Vaccination status: Unknown Imaging: Chest CT-Lung fields are clear.  There is no hilar mass or mediastinal hematoma seen. Chest x-ray 4/7/23no acute infiltrate or fluid overload Oxygen requirements on admission: Room air Current oxygen requirements: 2LMedical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants f  Medical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants following: None Anticipated special isolation end date: 4/15/2023  FEES 4/10 with trace penetration - thin liquids recommended Discharged stable on room air   Hypokalemiaresolved Premature ventricular complexes Required aggressive IV electrolyte replacement over last 72 hours Potassium level up to 3.8  Possible blood per rectum Colon thickening on CT Nursing staff expresses concerns about bloodstained  bedsheets, negative FOBT Stable hgb  Diarrheaimproving Negative stool for C. difficile, stool PCR Continue IV fluid resuscitation  Severe vitamin D deficiency Started oral vitamin D replacement therapy   Elevated troponin Atrial fibrillation Noncompliant with Eliquis at home Troponin 47< 58 EKG -A-fib , T wave inversion in V3 to V6, PVC Hypotensive on presentation, blood pressure starting to stabilize, Continue Eliquis, carvedilol with holding parameters Alcohol use disorder Drinks a liter of tequila every day On CIWA protocolmost recent score 0 Continue with thiamine folic acid and multivitamin   Recurrent fall at home Deconditioning Secondary to generalized deconditioning, chronic alcohol use CT chest abdomen pelvis-no acute pathology CT TLS spine-no acute fracture PT OT eval - ampac 8 Case management consult for discharge needs-patient refusing to go to skilled nursing facility, discharge with HHC Working daily with pt to improve mobility for safe homegoing
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Clostridium test negative, Computerised tomogram abdomen abnormal, Computerised tomogram normal, Computerised tomogram spine, Computerised tomogram thorax normal
Clinical narrative: 71 y.o. male patient with history of A-fib, COPD, CAD, alcohol use disorder presented to Hospital following a fall at home. Covid positive with hypoxia.   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms:4/4/23 Symptoms present on admission: Chest congestion, diarrhea Date of covid positive test: 4/5/2023 Vaccination status: Unknown Imaging: Chest CT-Lung fields are clear.  There is no hilar mass or mediastinal hematoma seen. Chest x-ray 4/7/23no acute infiltrate or fluid overload Oxygen requirements on admission: Room air Current oxygen requirements: 2LMedical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants f  Medical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants following: None Anticipated special isolation end date: 4/15/2023  FEES 4/10 with trace penetration - thin liquids recommended Discharged stable on room air   Hypokalemiaresolved Premature ventricular complexes Required aggressive IV electrolyte replacement over last 72 hours Potassium level up to 3.8  Possible blood per rectum Colon thickening on CT Nursing staff expresses concerns about bloodstained  bedsheets, negative FOBT Stable hgb  Diarrheaimproving Negative stool for C. difficile, stool PCR Continue IV fluid resuscitation  Severe vitamin D deficiency Started oral vitamin D replacement therapy   Elevated troponin Atrial fibrillation Noncompliant with Eliquis at home Troponin 47< 58 EKG -A-fib , T wave inversion in V3 to V6, PVC Hypotensive on presentation, blood pressure starting to stabilize, Continue Eliquis, carvedilol with holding parameters Alcohol use disorder Drinks a liter of tequila every day On CIWA protocolmost recent score 0 Continue with thiamine folic acid and multivitamin   Recurrent fall at home Deconditioning Secondary to generalized deconditioning, chronic alcohol use CT chest abdomen pelvis-no acute pathology CT TLS spine-no acute fracture PT OT eval - ampac 8 Case management consult for discharge needs-patient refusing to go to skilled nursing facility, discharge with HHC Working daily with pt to improve mobility for safe homegoing
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Diarrhoea, Electrocardiogram T wave inversion, Electrolyte substitution therapy, Fall
Clinical narrative: 71 y.o. male patient with history of A-fib, COPD, CAD, alcohol use disorder presented to Hospital following a fall at home. Covid positive with hypoxia.   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms:4/4/23 Symptoms present on admission: Chest congestion, diarrhea Date of covid positive test: 4/5/2023 Vaccination status: Unknown Imaging: Chest CT-Lung fields are clear.  There is no hilar mass or mediastinal hematoma seen. Chest x-ray 4/7/23no acute infiltrate or fluid overload Oxygen requirements on admission: Room air Current oxygen requirements: 2LMedical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants f  Medical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants following: None Anticipated special isolation end date: 4/15/2023  FEES 4/10 with trace penetration - thin liquids recommended Discharged stable on room air   Hypokalemiaresolved Premature ventricular complexes Required aggressive IV electrolyte replacement over last 72 hours Potassium level up to 3.8  Possible blood per rectum Colon thickening on CT Nursing staff expresses concerns about bloodstained  bedsheets, negative FOBT Stable hgb  Diarrheaimproving Negative stool for C. difficile, stool PCR Continue IV fluid resuscitation  Severe vitamin D deficiency Started oral vitamin D replacement therapy   Elevated troponin Atrial fibrillation Noncompliant with Eliquis at home Troponin 47< 58 EKG -A-fib , T wave inversion in V3 to V6, PVC Hypotensive on presentation, blood pressure starting to stabilize, Continue Eliquis, carvedilol with holding parameters Alcohol use disorder Drinks a liter of tequila every day On CIWA protocolmost recent score 0 Continue with thiamine folic acid and multivitamin   Recurrent fall at home Deconditioning Secondary to generalized deconditioning, chronic alcohol use CT chest abdomen pelvis-no acute pathology CT TLS spine-no acute fracture PT OT eval - ampac 8 Case management consult for discharge needs-patient refusing to go to skilled nursing facility, discharge with HHC Working daily with pt to improve mobility for safe homegoing
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Gastrointestinal wall thickening, Haemoglobin normal, Hypokalaemia, Hypotension, Hypoxia
Clinical narrative: 71 y.o. male patient with history of A-fib, COPD, CAD, alcohol use disorder presented to Hospital following a fall at home. Covid positive with hypoxia.   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms:4/4/23 Symptoms present on admission: Chest congestion, diarrhea Date of covid positive test: 4/5/2023 Vaccination status: Unknown Imaging: Chest CT-Lung fields are clear.  There is no hilar mass or mediastinal hematoma seen. Chest x-ray 4/7/23no acute infiltrate or fluid overload Oxygen requirements on admission: Room air Current oxygen requirements: 2LMedical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants f  Medical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants following: None Anticipated special isolation end date: 4/15/2023  FEES 4/10 with trace penetration - thin liquids recommended Discharged stable on room air   Hypokalemiaresolved Premature ventricular complexes Required aggressive IV electrolyte replacement over last 72 hours Potassium level up to 3.8  Possible blood per rectum Colon thickening on CT Nursing staff expresses concerns about bloodstained  bedsheets, negative FOBT Stable hgb  Diarrheaimproving Negative stool for C. difficile, stool PCR Continue IV fluid resuscitation  Severe vitamin D deficiency Started oral vitamin D replacement therapy   Elevated troponin Atrial fibrillation Noncompliant with Eliquis at home Troponin 47< 58 EKG -A-fib , T wave inversion in V3 to V6, PVC Hypotensive on presentation, blood pressure starting to stabilize, Continue Eliquis, carvedilol with holding parameters Alcohol use disorder Drinks a liter of tequila every day On CIWA protocolmost recent score 0 Continue with thiamine folic acid and multivitamin   Recurrent fall at home Deconditioning Secondary to generalized deconditioning, chronic alcohol use CT chest abdomen pelvis-no acute pathology CT TLS spine-no acute fracture PT OT eval - ampac 8 Case management consult for discharge needs-patient refusing to go to skilled nursing facility, discharge with HHC Working daily with pt to improve mobility for safe homegoing
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Occult blood negative, Physical deconditioning, Respiratory tract congestion, SARS-CoV-2 test positive, Stool analysis normal
Clinical narrative: 71 y.o. male patient with history of A-fib, COPD, CAD, alcohol use disorder presented to Hospital following a fall at home. Covid positive with hypoxia.   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms:4/4/23 Symptoms present on admission: Chest congestion, diarrhea Date of covid positive test: 4/5/2023 Vaccination status: Unknown Imaging: Chest CT-Lung fields are clear.  There is no hilar mass or mediastinal hematoma seen. Chest x-ray 4/7/23no acute infiltrate or fluid overload Oxygen requirements on admission: Room air Current oxygen requirements: 2LMedical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants f  Medical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants following: None Anticipated special isolation end date: 4/15/2023  FEES 4/10 with trace penetration - thin liquids recommended Discharged stable on room air   Hypokalemiaresolved Premature ventricular complexes Required aggressive IV electrolyte replacement over last 72 hours Potassium level up to 3.8  Possible blood per rectum Colon thickening on CT Nursing staff expresses concerns about bloodstained  bedsheets, negative FOBT Stable hgb  Diarrheaimproving Negative stool for C. difficile, stool PCR Continue IV fluid resuscitation  Severe vitamin D deficiency Started oral vitamin D replacement therapy   Elevated troponin Atrial fibrillation Noncompliant with Eliquis at home Troponin 47< 58 EKG -A-fib , T wave inversion in V3 to V6, PVC Hypotensive on presentation, blood pressure starting to stabilize, Continue Eliquis, carvedilol with holding parameters Alcohol use disorder Drinks a liter of tequila every day On CIWA protocolmost recent score 0 Continue with thiamine folic acid and multivitamin   Recurrent fall at home Deconditioning Secondary to generalized deconditioning, chronic alcohol use CT chest abdomen pelvis-no acute pathology CT TLS spine-no acute fracture PT OT eval - ampac 8 Case management consult for discharge needs-patient refusing to go to skilled nursing facility, discharge with HHC Working daily with pt to improve mobility for safe homegoing
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Troponin increased, Ventricular extrasystoles, Vitamin D deficiency, Vitamin supplementation
Clinical narrative: 71 y.o. male patient with history of A-fib, COPD, CAD, alcohol use disorder presented to Hospital following a fall at home. Covid positive with hypoxia.   Acute respiratory failure with hypoxia Covid-19 Virus Infection Date of onset of symptoms:4/4/23 Symptoms present on admission: Chest congestion, diarrhea Date of covid positive test: 4/5/2023 Vaccination status: Unknown Imaging: Chest CT-Lung fields are clear.  There is no hilar mass or mediastinal hematoma seen. Chest x-ray 4/7/23no acute infiltrate or fluid overload Oxygen requirements on admission: Room air Current oxygen requirements: 2LMedical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants f  Medical therapy: Decadron 4/8 started, remdesivir completed therapy Consultants following: None Anticipated special isolation end date: 4/15/2023  FEES 4/10 with trace penetration - thin liquids recommended Discharged stable on room air   Hypokalemiaresolved Premature ventricular complexes Required aggressive IV electrolyte replacement over last 72 hours Potassium level up to 3.8  Possible blood per rectum Colon thickening on CT Nursing staff expresses concerns about bloodstained  bedsheets, negative FOBT Stable hgb  Diarrheaimproving Negative stool for C. difficile, stool PCR Continue IV fluid resuscitation  Severe vitamin D deficiency Started oral vitamin D replacement therapy   Elevated troponin Atrial fibrillation Noncompliant with Eliquis at home Troponin 47< 58 EKG -A-fib , T wave inversion in V3 to V6, PVC Hypotensive on presentation, blood pressure starting to stabilize, Continue Eliquis, carvedilol with holding parameters Alcohol use disorder Drinks a liter of tequila every day On CIWA protocolmost recent score 0 Continue with thiamine folic acid and multivitamin   Recurrent fall at home Deconditioning Secondary to generalized deconditioning, chronic alcohol use CT chest abdomen pelvis-no acute pathology CT TLS spine-no acute fracture PT OT eval - ampac 8 Case management consult for discharge needs-patient refusing to go to skilled nursing facility, discharge with HHC Working daily with pt to improve mobility for safe homegoing
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Angina pectoris
Clinical narrative: STABLE ANGINA
Age: 71.0
Sex: F
Vaccine: TYP
Symptoms: Immediate post-injection reaction, Immunisation reaction, Pruritus
Clinical narrative: Patient called to report that she "immediately started itching "- described as having a reaction to her first oral typhoid pill,
Age: 79.0
Sex: M
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 4.0
Sex: F
Vaccine: COVID19-2, DTAP, IPV, MMRV
Symptoms: Underdose
Clinical narrative: Given 10 mcg Moderna Bivalent instead of 25 mcg
Age: 74.0
Sex: M
Vaccine: COVID19-2
Symptoms: Acute myocardial infarction, Angina pectoris, Symptom recurrence
Clinical narrative: ANGINA, UNSPECIFIED ACUTE ST ELEVATION MI, ANTERIOR WALL 3/13/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 4.0
Sex: F
Vaccine: COVID19-2, DTAP, IPV, MMRV
Symptoms: Underdose
Clinical narrative: Given 10 mcg Moderna bivalent instead of 25 mcg
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 0.5
Sex: M
Vaccine: COVID19-2, DTAPIPVHIB, PNC15, RV5
Symptoms: Underdose
Clinical narrative: Given 10 mcg Moderna Bivalent instead of 25 mcg
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: OBSTRUCTIVE SLEEP APNEA
Age: 0.5
Sex: F
Vaccine: COVID19-2, DTAP, PNC15, RV5
Symptoms: Underdose
Clinical narrative: Given 10 mcg Moderna Bivalent instead of 25 mcg
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Angiogram pulmonary normal, Blast cells present, Blood culture negative, Blood lactic acid increased
Clinical narrative: Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Blood potassium decreased, Body temperature increased, Brain natriuretic peptide increased, COVID-19 pneumonia, Computerised tomogram thorax abnormal
Clinical narrative: Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, Echocardiogram normal, Ejection fraction, Glycosylated haemoglobin increased
Clinical narrative: Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Hypokalaemia, Hypovolaemia, Hypoxia, Infection, Leukocytosis
Clinical narrative: Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Lung infiltration, Malaise, Monocyte count, Mycoplasma test negative, Platelet count decreased
Clinical narrative: Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Procalcitonin, Respiratory tract congestion, SARS-CoV-2 test positive, Sepsis, Sinus tachycardia
Clinical narrative: Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Smear test, Sputum culture, Tachycardia, Tachypnoea, Thrombocytopenia
Clinical narrative: Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Urine antigen test, White blood cell count increased
Clinical narrative: Patient is a 39 y.o. male patient of, DO with history of non-insulin-dependent diabetes type 2, obesity, hypertension,, hyperlipidemia  presented to Hospital with complaints of shortness of breath and hypoxia.   Acute hypoxic respiratory failure Severe sepsis secondary to COVID-19 viral pneumonia  Date of onset of symptoms: 30 days Symptoms present on admission: Cough, congestion, hypoxia.  Found to have tachycardia, tachypnea, Tmax 101.5, elevated LA, and leukocytosis for severe sepsis  Date of covid positive test: 4/5/2023 Vaccination status: vaccinated Imaging: CT with extensive bilateral patchy infiltrates Oxygen requirements on admission: 5 L nasal cannula Current oxygen requirements: 8 L nasal cannula Medical therapy: Steroids, Levaquin, Ceftriaxone  Consultants following: N/A Anticipated special isolation end date: TBD Urinary Ags negative, Mycoplasma negative, blood cultures x2 NGTD, sputum culture pending, pro-cal 0.36 Bronchodilators, Mucinex, Tessalon Perles Wean O2 requirements as able   Concern for acute myeloid leukemia Leukocytosis WBC 30.79 Peripheral smear reviewed by pathology- leukocytosis with predominance of monocytes including immature forms accompanied by blasts Discussed with Dr. (Oncology) who recommended transfer to Facility Accepted at Facility, awaiting bed assignment    Sinus tachycardia Suspecting secondary to underlying infection and hypovolemia CTPA negative for PE Echo shows LVEF 58%    Elevated BNP BNP 971  Low suspicion for CHF exacerbation Echo wnl   Hypokalemia K 3.2 Replace with 40 mEq   Type 2 NIDDM Hold home oral agents HbA1c 9.5 on 3/1/23 SSI with accu-checks    Thrombocytopenia Suspecting secondary to underlying infection Plts 46 Transfuse if Hb <7   Disposition Estimated Discharge Date: 4/6/23 Discharge Location: Facility
Age: 59.0
Sex: F
Vaccine: COVID19-2
Symptoms: Acute respiratory failure
Clinical narrative: ACUTE HYPOXEMIC RESPIRATORY FAILURE
Age: 80.0
Sex: F
Vaccine: COVID19-2
Symptoms: Neuropathy peripheral
Clinical narrative: PERIPHERAL NEUROPATHY
Age: 0.5
Sex: M
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Given 10 mcg Moderna Bivalent instead of 25 mcg
Age: 1.08
Sex: M
Vaccine: HEPA, HIBV, MMR, VARCEL
Symptoms: Culture urine, Influenza A virus test, Influenza B virus test, Measles, Pyrexia
Clinical narrative: Patient presented to clinic on 7/11/2023 with generalized body rash, measle like, fever
Age: 1.08
Sex: M
Vaccine: HEPA, HIBV, MMR, VARCEL
Symptoms: Rash, SARS-CoV-2 test, Urine analysis
Clinical narrative: Patient presented to clinic on 7/11/2023 with generalized body rash, measle like, fever
Age: 0.5
Sex: M
Vaccine: COVID19-2, DTAPIPVHIB, PNC15, RV5
Symptoms: Underdose
Clinical narrative: Given 10 mcg Moderna bivalent instead of 25 mcg
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Headache, Injection site erythema, Injection site mass, Injection site pain, Injection site swelling
Clinical narrative: Patient received the menquafi vaccine to her right deltoid on Thursday afternoon, 7/6/23. Later that evening at home she developed a headache, nausea and her throat felt weird. Her entire upper right arm was red, swollen, warm and painful.  Mom also reported an egg size lump at injection site. The next day it was worse. She was seen Saturday 7/8/23 at the clinic for large area of erythema of right arm with swelling and increased warmth. The area was marked with blue surgical pen. She was prescribed an antibiotic and steroid suspension along with Benadryl.  Patient was seen 2 days later. The area was less red but the area itself remained the same. She will continue to use ice packs to area and finish the antibiotics and prednisolone. She will return if symptoms worsen or fail to improve. Local DOH was called to report and given info to report here.
Age: 11.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site warmth, Nausea, Oropharyngeal discomfort
Clinical narrative: Patient received the menquafi vaccine to her right deltoid on Thursday afternoon, 7/6/23. Later that evening at home she developed a headache, nausea and her throat felt weird. Her entire upper right arm was red, swollen, warm and painful.  Mom also reported an egg size lump at injection site. The next day it was worse. She was seen Saturday 7/8/23 at the clinic for large area of erythema of right arm with swelling and increased warmth. The area was marked with blue surgical pen. She was prescribed an antibiotic and steroid suspension along with Benadryl.  Patient was seen 2 days later. The area was less red but the area itself remained the same. She will continue to use ice packs to area and finish the antibiotics and prednisolone. She will return if symptoms worsen or fail to improve. Local DOH was called to report and given info to report here.
Age: 69.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Inflammation, Pain, Skin warm
Clinical narrative: redness and inflammation about size of silver dollar, white round nickel size spot in the middle of redness, hot to touch and sore
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Pancreatic mass
Clinical narrative: Started having abdominal pain, eventually diagnosed with pancreatic mass 7/2023
Age: 6.0
Sex: F
Vaccine: COVID19-2
Symptoms: Underdose
Clinical narrative: Patient was given a maroon top indicated for patients 6 months to <5 years. Patient should have received an orange top vaccine indicated for ages 5-<11 years. Contacted CDC for direction, they sent information regarding how to handle. Shared information with Dr, he advised to contact patient and inform them to have the correct vaccine dose administered ASAP. Patient's mother states she will contact the resource provided to her to schedule the vaccine.
Age: 18.0
Sex: F
Vaccine: UNK
Symptoms: COVID-19, Central cord syndrome, Coma scale, Computerised tomogram, Cranial nerve paralysis
Clinical narrative: TRAUMA SURGERY PROGRESS NOTE              Hospital Day(s): 31   Injuries:  (s/p MVC on 6/9/23; Repatriated from Medical Center on 6/10/2023) ? Traumatic pons SAH ? Left occipital condyle fracture ? Possible B ICA, vert artery dissection ? C1 ring fracture ? C-spine epidural hematoma ? L humerus fx x2 - displaced distal midshaft, nondisplaced proximal midshaft      Other Diagnoses: ? Bilateral true vocal fold paresis ? Vertical diplopia 2/2 CN 4 palsy ? Central cord syndrome, left upper extremity weakness ? Respiratory Failure ? Dysphagia ? Possible Pneumonia ? Covid 19 disease   Operations & Procedures: ? 6/9:     Endotracheal intubation ? 6/12:   Cranio-cervical (C5) fusion ? 6/13:   Left humerus ORIF ? 6/17:   Perc Trach ? 6/21:   Percutaneous gastrostomy    Transfusions: ? 6/12 1 u PRBC   Summary / Hospital Course: Patient is an 18 Y old Female status post motor vehicle collision who was initially taken to Medical Center for initial trauma evaluation and care on 6/9/2023. Pt was an  unrestrained passenger.  After a thorough trauma evaluation, the patient was taken to ICU for traumatic SAH and C1 fx.  While at Medical Center pt immediately intubated for GCS 3. Per NB ED documentation, deformity noted to Left arm, abrasions to L buttock, Right  knee, and bilateral hands. There was question of possible seizure activity, for which pt was administered 2mg ativan. Posterior long arm and sugar tong splint placed on LUE.  Transfer was requested for a higher level of care and she was transferred late on 6/10/23 and admitted to the ICU.   Immediately upon arrival, appropriate CTs and MRIs were obtained.  She was kept in very strict spine immobilization and Neurosurgery was consulted.  She has remained very sedated overnight to avoid any movement.   6/11:  Ortho consult.  Continue splint until ORIF after Cspine stabilized.  Continue deep sedation today.  Family counseled by NS.  EN started via OGT. 6/12:  Cranio-cervical fusion performed.  To ICU intubated.  Per RN, 2/5 motor RLE, 1/5 LLE, No movement BUE. 6/13:  Left humerus ORIF.  Moving BLEs; no BUE motor. 6/14 on steroids for central cord syndrome.  Vasopressors available but not needed for MAP therapy
Age: 18.0
Sex: F
Vaccine: UNK
Symptoms: Diplopia, Dysphagia, Endotracheal intubation, Gastrostomy, Humerus fracture
Clinical narrative: TRAUMA SURGERY PROGRESS NOTE              Hospital Day(s): 31   Injuries:  (s/p MVC on 6/9/23; Repatriated from Medical Center on 6/10/2023) ? Traumatic pons SAH ? Left occipital condyle fracture ? Possible B ICA, vert artery dissection ? C1 ring fracture ? C-spine epidural hematoma ? L humerus fx x2 - displaced distal midshaft, nondisplaced proximal midshaft      Other Diagnoses: ? Bilateral true vocal fold paresis ? Vertical diplopia 2/2 CN 4 palsy ? Central cord syndrome, left upper extremity weakness ? Respiratory Failure ? Dysphagia ? Possible Pneumonia ? Covid 19 disease   Operations & Procedures: ? 6/9:     Endotracheal intubation ? 6/12:   Cranio-cervical (C5) fusion ? 6/13:   Left humerus ORIF ? 6/17:   Perc Trach ? 6/21:   Percutaneous gastrostomy    Transfusions: ? 6/12 1 u PRBC   Summary / Hospital Course: Patient is an 18 Y old Female status post motor vehicle collision who was initially taken to Medical Center for initial trauma evaluation and care on 6/9/2023. Pt was an  unrestrained passenger.  After a thorough trauma evaluation, the patient was taken to ICU for traumatic SAH and C1 fx.  While at Medical Center pt immediately intubated for GCS 3. Per NB ED documentation, deformity noted to Left arm, abrasions to L buttock, Right  knee, and bilateral hands. There was question of possible seizure activity, for which pt was administered 2mg ativan. Posterior long arm and sugar tong splint placed on LUE.  Transfer was requested for a higher level of care and she was transferred late on 6/10/23 and admitted to the ICU.   Immediately upon arrival, appropriate CTs and MRIs were obtained.  She was kept in very strict spine immobilization and Neurosurgery was consulted.  She has remained very sedated overnight to avoid any movement.   6/11:  Ortho consult.  Continue splint until ORIF after Cspine stabilized.  Continue deep sedation today.  Family counseled by NS.  EN started via OGT. 6/12:  Cranio-cervical fusion performed.  To ICU intubated.  Per RN, 2/5 motor RLE, 1/5 LLE, No movement BUE. 6/13:  Left humerus ORIF.  Moving BLEs; no BUE motor. 6/14 on steroids for central cord syndrome.  Vasopressors available but not needed for MAP therapy
Age: 18.0
Sex: F
Vaccine: UNK
Symptoms: Injury, Intensive care, Limb deformity, Magnetic resonance imaging, Mobility decreased
Clinical narrative: TRAUMA SURGERY PROGRESS NOTE              Hospital Day(s): 31   Injuries:  (s/p MVC on 6/9/23; Repatriated from Medical Center on 6/10/2023) ? Traumatic pons SAH ? Left occipital condyle fracture ? Possible B ICA, vert artery dissection ? C1 ring fracture ? C-spine epidural hematoma ? L humerus fx x2 - displaced distal midshaft, nondisplaced proximal midshaft      Other Diagnoses: ? Bilateral true vocal fold paresis ? Vertical diplopia 2/2 CN 4 palsy ? Central cord syndrome, left upper extremity weakness ? Respiratory Failure ? Dysphagia ? Possible Pneumonia ? Covid 19 disease   Operations & Procedures: ? 6/9:     Endotracheal intubation ? 6/12:   Cranio-cervical (C5) fusion ? 6/13:   Left humerus ORIF ? 6/17:   Perc Trach ? 6/21:   Percutaneous gastrostomy    Transfusions: ? 6/12 1 u PRBC   Summary / Hospital Course: Patient is an 18 Y old Female status post motor vehicle collision who was initially taken to Medical Center for initial trauma evaluation and care on 6/9/2023. Pt was an  unrestrained passenger.  After a thorough trauma evaluation, the patient was taken to ICU for traumatic SAH and C1 fx.  While at Medical Center pt immediately intubated for GCS 3. Per NB ED documentation, deformity noted to Left arm, abrasions to L buttock, Right  knee, and bilateral hands. There was question of possible seizure activity, for which pt was administered 2mg ativan. Posterior long arm and sugar tong splint placed on LUE.  Transfer was requested for a higher level of care and she was transferred late on 6/10/23 and admitted to the ICU.   Immediately upon arrival, appropriate CTs and MRIs were obtained.  She was kept in very strict spine immobilization and Neurosurgery was consulted.  She has remained very sedated overnight to avoid any movement.   6/11:  Ortho consult.  Continue splint until ORIF after Cspine stabilized.  Continue deep sedation today.  Family counseled by NS.  EN started via OGT. 6/12:  Cranio-cervical fusion performed.  To ICU intubated.  Per RN, 2/5 motor RLE, 1/5 LLE, No movement BUE. 6/13:  Left humerus ORIF.  Moving BLEs; no BUE motor. 6/14 on steroids for central cord syndrome.  Vasopressors available but not needed for MAP therapy
Age: 18.0
Sex: F
Vaccine: UNK
Symptoms: Muscular weakness, Open reduction of fracture, Red blood cell transfusion, Respiratory failure, Skin abrasion
Clinical narrative: TRAUMA SURGERY PROGRESS NOTE              Hospital Day(s): 31   Injuries:  (s/p MVC on 6/9/23; Repatriated from Medical Center on 6/10/2023) ? Traumatic pons SAH ? Left occipital condyle fracture ? Possible B ICA, vert artery dissection ? C1 ring fracture ? C-spine epidural hematoma ? L humerus fx x2 - displaced distal midshaft, nondisplaced proximal midshaft      Other Diagnoses: ? Bilateral true vocal fold paresis ? Vertical diplopia 2/2 CN 4 palsy ? Central cord syndrome, left upper extremity weakness ? Respiratory Failure ? Dysphagia ? Possible Pneumonia ? Covid 19 disease   Operations & Procedures: ? 6/9:     Endotracheal intubation ? 6/12:   Cranio-cervical (C5) fusion ? 6/13:   Left humerus ORIF ? 6/17:   Perc Trach ? 6/21:   Percutaneous gastrostomy    Transfusions: ? 6/12 1 u PRBC   Summary / Hospital Course: Patient is an 18 Y old Female status post motor vehicle collision who was initially taken to Medical Center for initial trauma evaluation and care on 6/9/2023. Pt was an  unrestrained passenger.  After a thorough trauma evaluation, the patient was taken to ICU for traumatic SAH and C1 fx.  While at Medical Center pt immediately intubated for GCS 3. Per NB ED documentation, deformity noted to Left arm, abrasions to L buttock, Right  knee, and bilateral hands. There was question of possible seizure activity, for which pt was administered 2mg ativan. Posterior long arm and sugar tong splint placed on LUE.  Transfer was requested for a higher level of care and she was transferred late on 6/10/23 and admitted to the ICU.   Immediately upon arrival, appropriate CTs and MRIs were obtained.  She was kept in very strict spine immobilization and Neurosurgery was consulted.  She has remained very sedated overnight to avoid any movement.   6/11:  Ortho consult.  Continue splint until ORIF after Cspine stabilized.  Continue deep sedation today.  Family counseled by NS.  EN started via OGT. 6/12:  Cranio-cervical fusion performed.  To ICU intubated.  Per RN, 2/5 motor RLE, 1/5 LLE, No movement BUE. 6/13:  Left humerus ORIF.  Moving BLEs; no BUE motor. 6/14 on steroids for central cord syndrome.  Vasopressors available but not needed for MAP therapy
Age: 18.0
Sex: F
Vaccine: UNK
Symptoms: Skull fractured base, Spinal fusion surgery, Tracheostomy, Vertebrobasilar artery dissection, Vocal cord paresis
Clinical narrative: TRAUMA SURGERY PROGRESS NOTE              Hospital Day(s): 31   Injuries:  (s/p MVC on 6/9/23; Repatriated from Medical Center on 6/10/2023) ? Traumatic pons SAH ? Left occipital condyle fracture ? Possible B ICA, vert artery dissection ? C1 ring fracture ? C-spine epidural hematoma ? L humerus fx x2 - displaced distal midshaft, nondisplaced proximal midshaft      Other Diagnoses: ? Bilateral true vocal fold paresis ? Vertical diplopia 2/2 CN 4 palsy ? Central cord syndrome, left upper extremity weakness ? Respiratory Failure ? Dysphagia ? Possible Pneumonia ? Covid 19 disease   Operations & Procedures: ? 6/9:     Endotracheal intubation ? 6/12:   Cranio-cervical (C5) fusion ? 6/13:   Left humerus ORIF ? 6/17:   Perc Trach ? 6/21:   Percutaneous gastrostomy    Transfusions: ? 6/12 1 u PRBC   Summary / Hospital Course: Patient is an 18 Y old Female status post motor vehicle collision who was initially taken to Medical Center for initial trauma evaluation and care on 6/9/2023. Pt was an  unrestrained passenger.  After a thorough trauma evaluation, the patient was taken to ICU for traumatic SAH and C1 fx.  While at Medical Center pt immediately intubated for GCS 3. Per NB ED documentation, deformity noted to Left arm, abrasions to L buttock, Right  knee, and bilateral hands. There was question of possible seizure activity, for which pt was administered 2mg ativan. Posterior long arm and sugar tong splint placed on LUE.  Transfer was requested for a higher level of care and she was transferred late on 6/10/23 and admitted to the ICU.   Immediately upon arrival, appropriate CTs and MRIs were obtained.  She was kept in very strict spine immobilization and Neurosurgery was consulted.  She has remained very sedated overnight to avoid any movement.   6/11:  Ortho consult.  Continue splint until ORIF after Cspine stabilized.  Continue deep sedation today.  Family counseled by NS.  EN started via OGT. 6/12:  Cranio-cervical fusion performed.  To ICU intubated.  Per RN, 2/5 motor RLE, 1/5 LLE, No movement BUE. 6/13:  Left humerus ORIF.  Moving BLEs; no BUE motor. 6/14 on steroids for central cord syndrome.  Vasopressors available but not needed for MAP therapy
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, Incorrect product formulation administered, Product administration error
Clinical narrative: 1. Patient was administered Pfizer monovalent Covid vaccine after the authorization for use expired April 18, 2023. 2. Patient was prescribed Pfizer Bivalent and was administered Pfizer monovalent in error.
Age: 14.0
Sex: F
Vaccine: HPV9
Symptoms: Blood glucose normal, Blood pressure abnormal, Hyperhidrosis, Pallor, Presyncope
Clinical narrative: The patient experienced a near- syncope episode after vaccine administration. The event occurred in the parking lot as the patient was walking to her car. An injury was prevented as staff immediately ran to assist the patient. She was brought back into the clinic for observation and monitoring. She was diaphoretic and pale. The SBP was in the 70s, but vital signs were otherwise within normal limits. The patient was alert and oriented x3 throughout the observation.  The patient was monitored for 20 mins until blood pressure and condition stabilized. Vital signs before discharge were BP 95/62, HR 59, Spo2 99% on room air, and fingerstick blood sugar reading of 105.
Age: 38.0
Sex: M
Vaccine: HEPA, MNQ, SMALLMNK
Symptoms: Underdose
Clinical narrative: Patient received the wrong dose of Hep A. Patient was given 0.5 ml instead of 1ml
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Discontinued product administered
Clinical narrative: 1. Patient was admitted Pfizer monovalent Covid Vaccine after authorization for use had expired April 18, 2023 2. Patient was prescribed Pfizer Bivalent and was administered Pfizer monovalent in error.
Age: 12.0
Sex: F
Vaccine: HPV9
Symptoms: Computerised tomogram normal, Fall, Fatigue, Full blood count normal, Metabolic function test normal
Clinical narrative: Patient was seen in ER on 7/8/2023 for seizure. Per mother, patient had episodic seizure witness by mother that lasted approximately 1 minute. She sat down to eat popsicle then slumped over. Mildly fatigued after seizure.